Dahlman Rose Maintains Buy on Holly

Dahlman Rose is out with its report today on Holly

, maintaining Buy. In a note to clients, Dahlman Rose writes, "We are introducing estimates for the combined HollyFrontier, with the merger of the two mid-con pure plays closing tomorrow. We maintain our view from the announcement that enhanced scale into the most advantaged segment of the industry positions the company as an outperformer over the intermediate term." Dahlman Rose maintains an $83 PT on HOC. At the time of posting, shares of HOC were trading at $69.27, up 1.60% from Wednesday's close.